Aurora Cannabis Europe

Amsterdam, NetherlandsFounded 2018

Producer & Grower NASDAQ: ACB www.auroramj.com

Share:X / Twitter LinkedIn Suggest a correction

About Aurora Cannabis Europe

Aurora Cannabis Europe is the European subsidiary of Canadian cannabis giant Aurora Cannabis Inc. The Netherlands-based operation serves as the company's EU hub for medical cannabis distribution and regulatory affairs. Aurora uses the Dutch market as a gateway to supply medical cannabis across Europe.

Key Facts

1Parent company Aurora Cannabis is one of the largest cannabis companies globally, listed on NASDAQ
2Uses the Netherlands as a strategic European distribution hub
3Holds EU-GMP certifications for medical cannabis products
4Supplies medical cannabis to patients in Germany, the Netherlands, and other EU markets

Latest News

Aurora Cannabis Expands Veterans Program Amid ESG Focus Push

6d ago

ACB strengthens community outreach with expanded veteran support initiatives as cannabis companies prioritize social responsibility to attract institutional investors.

Aurora Cannabis Sets Q4 FY2026 Earnings Call Date

11d ago

ACB schedules investor conference call for fourth quarter and full-year fiscal 2026 results as company prepares annual financial disclosures.

View all ACB news

Frequently Asked Questions

Is Aurora Cannabis Europe publicly traded?

Aurora Cannabis Europe itself is a subsidiary, but parent company Aurora Cannabis Inc. trades on NASDAQ under ticker ACB and on the TSX.

What European markets does Aurora serve?

Aurora supplies medical cannabis to Germany (its largest European market), the Netherlands, Poland, and several other EU countries with legal medical cannabis programs.

Why is the European HQ in the Netherlands?

The Netherlands offers a well-established cannabis regulatory framework, strategic logistics position in Europe, and a history of progressive cannabis policy, making it an ideal base for EU operations.